Cargando…

The anticoagulants rivaroxaban and low molecular weight heparin prevent PICC-related upper extremity venous thrombosis in cancer patients

Peripherally inserted central catheter (PICC) is often applied in chemotherapy patients and commonly causes upper extremity venous thrombosis (UEVT), which should be prevented. To assess the preventive effects of the anticoagulants rivaroxaban and low molecular weight heparin (LMWH) on UEVT in patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Shoutian, Liu, Yongmei, Wei, Gang, Shi, Xueyan, Chen, Shaoping, Zhang, Xuehui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	3400
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882624/ https://www.ncbi.nlm.nih.gov/pubmed/31764785 http://dx.doi.org/10.1097/MD.0000000000017894

Ejemplares similares

The clinical features and related factors of PICC-related upper extremity asymptomatic venous thrombosis in cancer patients: A prospective study
por: Wang, Guorong, et al.
Publicado: (2020)

A meta-analysis of bridging anticoagulation between low molecular weight heparin and heparin
por: Tao, Ende, et al.
Publicado: (2020)

Efficacy and safety of rivaroxaban for the treatment of PICC-related upper extremity deep vein thrombosis in cancer patients: a retrospective study
por: Xu, Jiaxuan, et al.
Publicado: (2023)

A STROBE cohort study of 755 deep and superficial upper-extremity vein thrombosis
por: Ploton, Gaetan, et al.
Publicado: (2020)

Risk indicators for venous thrombosis in first-degree relatives of patients with recurrent venous thromboembolism in Chinese
por: Zhao, Lianxing, et al.
Publicado: (2016)

Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
por: Farge, Dominique, et al.
Publicado: (2015)

Efficacy of ultrasound-accelerated versus traditional catheter-directed thrombolysis in treatment of lower extremity deep venous thrombosis: A protocol for systematic review and meta-analysis
por: Ma, Shan, et al.
Publicado: (2021)

Pathophysiology, diagnosis and management of cerebral venous thrombosis: A comprehensive review
por: Ranjan, Redoy, et al.
Publicado: (2023)

Efficacy and safety of postural intervention on prevention of deep venous thrombosis of lower extremity in postpartum women with pregnancy-induced hypertension: A protocol for systematic review and meta-analysis
por: Chen, Jie, et al.
Publicado: (2021)

Pathogeny of cerebral venous thrombosis in SARS-Cov-2 infection: Case reports
por: Guendouz, Cécile, et al.
Publicado: (2021)

Prevention of venous thromboembolism in patients with cancer with direct oral anticoagulants: A systematic review and meta-analysis
por: Chen, Hailong, et al.
Publicado: (2020)

Monitoring of Anticoagulant Activity of Dabigatran and Rivaroxaban in the Presence of Heparins
por: Jakimczuk, Aleksandra, et al.
Publicado: (2022)

A rare complication of cerebral venous thrombosis during simple percutaneous coronary intervention: A case report
por: Lo, Ming Yuan, et al.
Publicado: (2021)

Feasibility of anticoagulation using low molecular-weight heparin during catheter-directed thrombolysis for lower extremity deep venous thrombosis
por: Li, Yonghui, et al.
Publicado: (2021)

Prognostic factors for venous thrombosis in patients with peripherally inserted central catheters: Protocol for a systematic review and meta-analysis
por: Gao, Yanling, et al.
Publicado: (2020)

Traumatic Venous Thrombosis in the Upper Extremity
Publicado: (1932)

Successful treatment of amniotic fluid embolism complicated by disseminated intravascular coagulation with rivaroxaban: A case report
por: Wu, Hai-Di, et al.
Publicado: (2020)

Rivaroxaban for the treatment of cerebral venous thrombosis
por: Esmaeili, Sara, et al.
Publicado: (2021)

A retrospective cohort study of disease-related risk factors for central venous catheter-related symptomatic thrombosis in intensive care unit inpatients
por: Kuang, Zhiming, et al.
Publicado: (2021)

Upper extremity deep vein thrombosis after migration of peripherally inserted central catheter (PICC): A case report
por: Wang, Kai, et al.
Publicado: (2017)

Appropriateness of rivaroxaban and apixaban dosing in hospitalized patients with a newly diagnosed nonvalvular atrial fibrillation at a single tertiary hospital
por: Alshibani, Mohannad
Publicado: (2023)

Daily 10 mg rivaroxaban as a therapy for ventricular thrombus related to left ventricular non-compaction cardiomyopathy: A case report
por: Sun, Huan, et al.
Publicado: (2018)

PB2661: UPPER LIMB VENOUS THROMBOSIS ASSOCIATED WITH PICC AND ITS INFLUENCING FACTORS IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Tang, Jie, et al.
Publicado: (2023)

Use of oral rivaroxaban in cerebral venous thrombosis
por: Maqsood, Muhammad, et al.
Publicado: (2020)

Resolution of massive left atrial appendage thrombi with rivaroxaban before balloon mitral commissurotomy in severe mitral stenosis: A case report and literature review
por: Li, Yuechun, et al.
Publicado: (2016)

Risk Factors of PICC-Related Venous Thrombosis in Breast Cancer Patients Undergoing Chemotherapy
por: Lin, Bing-Xin, et al.
Publicado: (2021)

Two Pediatric Patients with Splanchnic Venous Thrombosis as a Complication of Acute Pancreatitis Successfully Treated with Low-Molecular-Weight Heparin and Rivaroxaban
por: Capraro, Shannon, et al.
Publicado: (2022)

Rivaroxaban versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Gastrointestinal and Pancreatobiliary Cancer
por: Lee, Jang Ho, et al.
Publicado: (2019)

Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous Thromboembolism
por: Coleman, Craig I., et al.
Publicado: (2023)

Resuming anticoagulation in patients with atrial fibrillation experiencing intracranial hemorrhage
por: Wu, Victor Chien-Chia, et al.
Publicado: (2021)

The safety and efficacy of oral anticoagulants with dual versus single antiplatelet therapy in patients after percutaneous coronary intervention: A meta-analysis
por: Chen, Jie, et al.
Publicado: (2017)

A case report of PVOD patient combined with pulmonary embolism: Anticoagulation or not?
por: Yuan, Xiaoling, et al.
Publicado: (2017)

The Role of Warfarin and Rivaroxaban in the Treatment of Cerebral Venous Thrombosis
por: Fayyaz, Muniba, et al.
Publicado: (2019)

The complete recanalization of PICC-related venous thrombosis in cancer patients: A series of case reports
por: HUANG, ZUO-PING, et al.
Publicado: (2013)

Oncostatin M was associated with thrombosis in patients with atrial fibrillation
por: Xie, Jun, et al.
Publicado: (2017)

Identification of biomarkers of venous thromboembolism by bioinformatics analyses
por: Wang, Guiming, et al.
Publicado: (2018)

Echocardiographic diagnosis of anomalous pulmonary venous connections: Experience of 84 cases from 1 medical center
por: Zhang, Ziming, et al.
Publicado: (2016)

Clinical Outcomes of Anticoagulation Therapy in Patients With Symptomatic Spontaneous Isolated Dissection of the Superior Mesenteric Artery
por: Han, Youngjin, et al.
Publicado: (2016)

Efficacy and Safety of Oral Anticoagulants Versus Aspirin for Patients With Atrial Fibrillation: A Meta-Analysis
por: Zhang, Jing-Tao, et al.
Publicado: (2015)

Suboptimal use of non-vitamin K antagonist oral anticoagulants: Results from the RAMSES study
por: Başaran, Özcan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cj81bsgemtuor3enoimpf99hd2